CYTOBIOSCIENCE INC
Instrumentation combining nanoscience, microchip, and algorithms for ion channel research and disease analysis
- Sector
- Biotech
- Headquarters
- SAN ANTONIO, TX
- Founded
- 2014
- Latest Form D
- $1.5M, Mar 2018
- Total capital
- $9M
- Federal grants
- $438K
- 2 awards · 2017
- Rank in peer group#35 of 41
- Private capital raised
- $8.2M
- 3 Form D · last Mar 2018
- 103 months since last filing
- Federal contracts
- $387K
- 7 awards · Health and Human S
- Rank in Biotech#245 of 4373
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Upgrade Of In-house Automated Patch Clamp System$175K
- Federal contractHealth and Human S · Igf::ot::igf Service Contract For Cytopatch Automated Patch Clamp System$25K
- Private capital raisedForm D · SEC · 2nd filing$1.5M
- Federal grantHealth and Human S · Phase I · Dual optimization of solubility and viscosity for protein therapeutics$219K
- Federal grantHealth and Human S · Phase I · Dual optimization of solubility and viscosity for protein therapeutics$219K
- Federal contractHealth and Human S · Igf::cl::igf Services: Evaluation Of Drug Effects On Cardiac Ion Channels$20K
- Federal contractHealth and Human S · Automated Patch Clamp System For Electrophysiology Studies$161K
- Private capital raisedForm D · SEC · 1st filing$6.6M
Show 1 earlier federal award
- Federal contractHealth and Human S · Stably Transfected HERG-HEK293 Cells For In Vitro Electrophysiology$6K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
3 records have no date or no amount, so they aren’t placed on the timeline.
Standing among 41 peers
Line = medianBiotech · Platform
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alan R. DeanDirectorNamed in SEC Form D filings
- Ian R. ClementsDirectorNamed in SEC Form D filings
- James R. GarvinExecutive Officer, DirectorNamed in SEC Form D filings
- Paul R. CastellaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingPortable Physiological Transport UnitUSPTOApplication 15622522
- PendingPortable Physiological Transport UnitUSPTOApplication 62469649
Related companies, and why
- RIPTIDE THERAPEUTICS LLCSimilar federal contract value in Biotech · $400K in contracts
- TRITERPENOID THERAPEUTICS INCSimilar federal contract value in Biotech · $400K in contracts
- ENRICH BIOSYSTEMS INCSimilar federal contract value in Biotech · $400K in contracts
- SIGNABLOK, INC.Similar federal contract value in Biotech · $370K in contracts
- NUVOX PHARMA, L.L.C.Similar federal contract value in Biotech · $356K in contracts
- CLOVERLEAF BIO, INC.Similar federal contract value in Biotech · $355K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .